


The fund aims to provide long term growth by investing predominantly in the shares of smaller companies listed on the global stock markets.
| Name | % Net Assets |
|---|---|
| Dollarama | 3.1% |
| TransDigm Group | 3.0% |
| Wabtec | 3.0% |
| Paddy Power | 2.7% |
| Betsson | 2.7% |
| Cosmos Pharmaceutical | 2.6% |
| LKQ | 2.6% |
| Questcor Pharmaceuticals | 2.5% |
| Polaris Industries | 2.5% |
| Core Laboratories | 2.5% |
| Key | % Net Assets |
|---|---|
| 3.1% | |
| 3.0% | |
| 3.0% | |
| 2.7% | |
| 88.2% |
| Date | 20-Aug-2025 |
|---|---|
| NAV | 181.40p |
| Currency | GBP |
| Change | -0.50p |
| % | -0.27% |
| YTD change | 5.20p |
| YTD % | 2.95% |
| Fund Inception | 19/01/2012 |
|---|---|
| Fund Manager | n/a |
| TER | 1.84 (31-Dec-2010) |
| Minimum Investment | |
|---|---|
| Initial | n/a |
| Additional | n/a |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | n/a |
| Annual Mang't | 1.70% |
| Exit | n/a |
| Name | % |
|---|---|
| No risk data available. | |
You are here: research